A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
1 other identifier
observational
10,000
1 country
1
Brief Summary
This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2022
CompletedStudy Start
First participant enrolled
February 24, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2030
ExpectedFebruary 25, 2022
February 1, 2022
1.3 years
February 16, 2022
February 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
disease progression
the effect of NAFLD on CHB
3 years to 10 years
Eligibility Criteria
age \> 18 years chronic hepatitis B patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qin Ninglead
Study Sites (1)
Department and Institute of Infectious Disease
Wuhan, Hubei, 430030, China
Biospecimen
blood
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director and Chair of Department of Infectious Diseases
Study Record Dates
First Submitted
February 16, 2022
First Posted
February 25, 2022
Study Start
February 24, 2022
Primary Completion
June 24, 2023
Study Completion (Estimated)
June 24, 2030
Last Updated
February 25, 2022
Record last verified: 2022-02